Minoru Oshima

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 4

Top Topics

High Throughput Sequencing

Top Venues

Journal of hepato-biliary-pancreatic sciences

Journal of surgical oncology

BMC gastroenterology

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Hironobu Suto, Keiichi Okano, Minoru Oshima, Yasuhisa Ando, Hiroyuki Matsukawa, Shigeo Takahashi, Toru Shibata, Hideki Kamada, Tsutomu Masaki, Yasuyuki Suzuki
Prediction of local tumor control and recurrence-free survival in patients with pancreatic cancer undergoing curative resection after neoadjuvant chemoradiotherapy. Journal of surgical oncology 126 (2) (2022)
Minoru Oshima, Keiichi Okano, Hideki Kamada, Hironobu Suto, Yasuhisa Ando, Emi Ibuki, Ryo Ishikawa, Tsutomu Masaki, Reiji Haba, Yasuyuki Suzuki
P53 Immunolabeling in EUS-FNA Biopsy can Predict Low Resection Rate and Early Recurrence in Resectable or Borderline Resectable Pancreatic Cancer Treated with Neoadjuvant Therapy. Journal of hepato-biliary-pancreatic sciences (2022)
Hirotsugu Shiroma, Yasushi Totoki, Michael Noe, Yoichiro Nakatani, Masafumi Horie, Kenta Kawasaki, Hiromi Nakamura, Mihoko Saito-Adachi, Masami Suzuki, Erina Takai, Natsuko Hama, Ryota Higuchi, Seiko Hirono, Satoshi Shiba, Mamoru Kato, Eisaku Furukawa, Yasuhito Arai, Hirofumi Rokutan, Taiki Hashimoto, Shuichi Mitsunaga, Mitsuro Kanda, Hidenori Tanaka, So Takata, Ayaka Shimomura, Minoru Oshima, Wenzel M Hackeng, Tomoyuki Okumura, Keiichi Okano, Masakazu Yamamoto, Hiroki Yamaue, Chigusa Morizane, Koji Arihiro, Toru Furukawa, Toshiro Sato, Tohru Kiyono, Lodewijk A A Brosens, Laura D Wood, Ralph H Hruban, Tatsuhiro Shibata
Comprehensive Genomic Profiling of Neuroendocrine Carcinomas of the Gastrointestinal System. Cancer discovery (2021)
Minoru Oshima, Keiichi Okano, Hironobu Suto, Yasuhisa Ando, Hideki Kamada, Tsutomu Masaki, Shigeo Takahashi, Toru Shibata, Yasuyuki Suzuki
Changes and prognostic impact of inflammatory nutritional factors during neoadjuvant chemoradiotherapy for patients with resectable and borderline resectable pancreatic cancer. BMC gastroenterology 20 (1) (2020)